{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:48:42Z","timestamp":1790912922686,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023452","name":"Hanarth Fund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Royal Philips Electronics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["848101007"],"award-info":[{"award-number":["848101007"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejca.2026.116831","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:14:23Z","timestamp":1779725663000},"page":"116831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-7271","authenticated-orcid":false,"given":"Mark","family":"Schuiveling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella A.J.","family":"van Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4879-9187","authenticated-orcid":false,"given":"Laurens S.","family":"ter Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke C.","family":"van der Weerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1966-1063","authenticated-orcid":false,"given":"Rik J.","family":"Verheijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2400-0692","authenticated-orcid":false,"given":"Franchette","family":"van den Berkmortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-5846","authenticated-orcid":false,"given":"Christian U.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-3667","authenticated-orcid":false,"given":"Gerben E.","family":"Breimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-9216","authenticated-orcid":false,"given":"Femke H.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9624-9189","authenticated-orcid":false,"given":"Marye","family":"Boers-Sonderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Labots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem B.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-7704","authenticated-orcid":false,"given":"John B.A.G.","family":"Haanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3047-7892","authenticated-orcid":false,"given":"Geke A.P.","family":"Hospers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-6426","authenticated-orcid":false,"given":"Ellen","family":"Kapiteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djura","family":"Piersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"Simkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-3638","authenticated-orcid":false,"given":"Hans M.","family":"Westgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.R.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josien P.W.","family":"Pluim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0658-2745","authenticated-orcid":false,"given":"Paul J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4647-8830","authenticated-orcid":false,"given":"Willeke A.M.","family":"Blokx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitko","family":"Veta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karijn P.M.","family":"Suijkerbuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116831_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.26641","article-title":"Long-term survival in patients with advanced melanoma","volume":"7","author":"van Not","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2026.116831_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s43018-024-00730-3","article-title":"Clinical and translational attributes of immune-related adverse events","volume":"5","author":"Suijkerbuijk","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib3","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/ijc.34853","article-title":"A prediction model for response to immune checkpoint inhibition in advanced melanoma","volume":"154","author":"van Duin","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib4","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.21.01701","article-title":"Clinical models to define response and survival With anti\u2013PD-1 antibodies alone or combined With Ipilimumab in metastatic melanoma","volume":"40","author":"Pires da Silva","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.ejca.2026.116831_bib5","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jamaoncol.2019.2311","article-title":"Multiomics prediction of response rates to therapies to inhibit programmed cell death 1 and programmed cell death 1 ligand 1","volume":"5","author":"Lee","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/2025.05.28.25328410","article-title":"Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma","author":"Schuiveling","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib7","article-title":"Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma","volume":"208","author":"Duin","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.aaf2834","article-title":"The \u201ccancer immunogram","volume":"352","author":"Blank","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejca.2026.116831_bib9","doi-asserted-by":"crossref","unstructured":"Song A.H., Chen R.J., Ding T., Williamson D.F.K., Jaume G., Mahmood F. Morphological Prototyping for Unsupervised Slide Representation Learning in Computational Pathology 2024. \u3008https:\/\/doi.org\/10.48550\/arXiv.2405.11643\u3009.","DOI":"10.1109\/CVPR52733.2024.01099"},{"key":"10.1016\/j.ejca.2026.116831_bib10","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1158\/1078-0432.CCR-24-3720","article-title":"Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors","volume":"31","author":"Fa\u2019ak","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116831_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejca.2016.11.021","article-title":"Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands","volume":"72","author":"Jochems","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib12","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.ejca.2026.116831_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib14","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2026.116831_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2026.116831_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/jnci\/djp335","article-title":"Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers","volume":"101","author":"Simon","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2026.116831_bib17","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib18","doi-asserted-by":"crossref","unstructured":"Lucassen R.T., Blokx W.A.M., Veta M. Tissue Cross-Section and Pen Marking Segmentation in Whole Slide Images 2024. \u3008https:\/\/doi.org\/10.48550\/arXiv.2401.13511\u3009.","DOI":"10.1117\/12.3004683"},{"key":"10.1016\/j.ejca.2026.116831_bib19","doi-asserted-by":"crossref","unstructured":"W\u00f6lflein G., Ferber D., Meneghetti A.R., Nahhas O.S.M.E., Truhn D., Carrero Z.I., et al. A Good Feature Extractor Is All You Need for Weakly Supervised Pathology Slide Classification 2024. \u3008https:\/\/doi.org\/10.48550\/arXiv.2311.11772\u3009.","DOI":"10.1007\/978-3-031-91721-9_5"},{"key":"10.1016\/j.ejca.2026.116831_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2026.116831_bib21","unstructured":"Ilse M., Tomczak J.M., Welling M. Attention-based Deep Multiple Instance Learning 2018. \u3008https:\/\/doi.org\/10.48550\/arXiv.1802.04712\u3009."},{"key":"10.1016\/j.ejca.2026.116831_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41551-020-00682-w","article-title":"Data-efficient and weakly supervised computational pathology on whole-slide images","volume":"5","author":"Lu","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ejca.2026.116831_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12859-024-05758-x","article-title":"Slideflow: deep learning for digital histopathology with real-time whole-slide visualization","volume":"25","author":"Dolezal","year":"2024","journal-title":"BMC Bioinforma"},{"key":"10.1016\/j.ejca.2026.116831_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaf011","article-title":"A novel dataset for nuclei and tissue segmentation in melanoma with baseline nuclei segmentation and tissue segmentation benchmarks","volume":"14","author":"Schuiveling","year":"2025","journal-title":"GigaScience"},{"key":"10.1016\/j.ejca.2026.116831_bib25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-024-02857-3","article-title":"Towards a general-purpose foundation model for computational pathology","volume":"30","author":"Chen","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2026.116831_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104644","article-title":"Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases","volume":"93","author":"Chatziioannou","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ejca.2026.116831_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100921","article-title":"Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images","volume":"14","author":"Hu","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1078-0432.CCR-20-2415","article-title":"Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma","volume":"27","author":"Johannet","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116831_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2023.03.032","article-title":"Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis","volume":"187","author":"Hench","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib30","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.2147\/CMAR.S319480","article-title":"Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma","volume":"13","author":"Lu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejca.2026.116831_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamadermatol.2022.4959","article-title":"Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies","volume":"159","author":"Stephens","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116831_bib32","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1245\/s10434-022-11478-4","article-title":"Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort","volume":"29","author":"Straker","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib33","doi-asserted-by":"crossref","first-page":"S696","DOI":"10.1016\/j.annonc.2023.09.2986","article-title":"1170P Survival outcome prediction of primary melanoma tumours from histology images using deep learning","volume":"34","author":"Bossard","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-19-1495","article-title":"Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death","volume":"26","author":"Kulkarni","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116831_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-024-08378-w","article-title":"A vision\u2013language foundation model for precision oncology","volume":"638","author":"Xiang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2026.116831_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/jamaoncol.2024.5356","article-title":"Deep Learning Model for Predicting Immunotherapy Response in Advanced Non\u2212Small Cell Lung Cancer","volume":"11","author":"Rakaee","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004329","article-title":"Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome","volume":"10","author":"Gorris","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib38","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12967-019-2039-4","article-title":"Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach","volume":"17","author":"Manca","year":"2019","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.ejca.2026.116831_bib40","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00018","article-title":"BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma","author":"van Not","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib41","series-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","first-page":"329","article-title":"Validation of Prediction Models","author":"Steyerberg","year":"2019"},{"key":"10.1016\/j.ejca.2026.116831_bib42","unstructured":"Jong E.D. de, Marcus E., Teuwen J. Current Pathology Foundation Models are unrobust to Medical Center Differences 2025. \u3008https:\/\/doi.org\/10.48550\/arXiv.2501.18055\u3009."},{"key":"10.1016\/j.ejca.2026.116831_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/pcmr.12340","article-title":"PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1\/PD-L1 clinical trials","volume":"28","author":"Madore","year":"2015","journal-title":"Pigment Cell & Melanoma Res"},{"key":"10.1016\/j.ejca.2026.116831_bib44","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","article-title":"Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: a systematic review and meta-analysis","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116831_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejca.2026.116831_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2021.11.012","article-title":"Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance","volume":"40","author":"Newell","year":"2022","journal-title":"Cancer Cell"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492600612X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492600612X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:11:30Z","timestamp":1783199490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492600612X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S095980492600612X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116831","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116831"}}